Archives

Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update

B STATEN ISLAND, N.Y., April 20, 2026 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new… Login to continue reading Login…

Read MoreAcurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update

5,000 Miles for a Cure: Human Powered Potential Announces “Second Wave” Row to Raise Funds to End Parkinson’s Disease

B HPP’s ‘Second Wave’ Team Kicks Off Training for Record-Setting Next Row SANFORD, Fla., April 20, 2026 /PRNewswire/ — During Parkinson’s Awareness Month, a team… Login to continue reading Login…

Read More5,000 Miles for a Cure: Human Powered Potential Announces “Second Wave” Row to Raise Funds to End Parkinson’s Disease